Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tecentriq (atezolizumab) Disease area(s): Oncology Manufacturer(s): Roche 2024 Sales (USD): $4.13 billion Why it sold so well: In 2024, Roches cancer immunotherapy Tecentriq posted global sales of CHF 3.64 billion ($4.13 billion) and was the companys fourth best-selling drug after MS drug Ocrevus, hemophilia treatment Hemlibra and eye drug Vabysmo
Schmitt, B., Vicenzi, M., Garrel, C., & Denis, F
Many manufacturers already provide direct-to-consumer discounts (e.g., Lilly Direct)
Many people are surprised to learn how common these concerns are and how many tailored options exist to address them
US$ 25.24
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 28.27
US$ 23.02
US$ 28.64
